Results 181 to 190 of about 1,371,279 (341)
Can we grasp and preserve the fleetingness of 19th-century fairs through digital humanities?
, 2023 Eva Andersen
openalex +1 more source
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Molecular Oncology, EarlyView.Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
Teaching medical ethics through Ethical Grand Rounds. [PDF]
Korean J Med EducKim MJ, Kim CJ.
europepmc +1 more source
PhilosophiesOnly the incurious and philosophically challenged doubt the significance of dignity as a central issue in human interactions. Human dignity is much debated in religion, law, moral philosophy, anthropology, psychiatry, bioethics, sociology, philosophical anthropology, psychology, communication studies, and elsewhere.
openaire +2 more sources
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
Molecular Oncology, EarlyView.CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source
Integrating medical humanities in undergraduate medical education: a curricular model aligned with the InspirE5 framework. [PDF]
BMC Med EducCoronado-Vázquez V +5 more
europepmc +1 more source
Archaeology in the Digital Age: From Paper to Databases
, 2015 Research units in archaeology often manage large and precious archives containing various documents, including reports on fieldwork, scholarly studies and reference books.
Ferguth, Johan +3 more
core
Molecular Oncology, EarlyView.Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source